1. Share Prices

  2. Ondine Biomedical Inc. (OBI)

7.00p+0.00 (+0.00%)09 May 2024, 17:08
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Ondine Biomedical Inc. Fundamentals

Company NameOndine Biomedical Inc.Last Updated2024-05-09
IndustryBiotechnologySectorHealthcare
Shares in Issue226.754 mMarket Cap£15.87 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-0.10 CADEPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0986Debt Equity Ratio0.0794
Asset Equity Ratio1.7867Cash Equity Ratio1.0709
Quick Ratio1.7111Current Ratio2.34
Price To Book Value6.5746ROCE0

Ondine Biomedical Inc. Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Ondine Biomedical Inc. Company Financials

Assets20222021
Tangible Assets1.40 m CAD601,000.00 CAD
Intangible Assets00
Investments00
Total Fixed Assets1.44 m CAD636,000.00 CAD
Stocks1.29 m CAD1.06 m CAD
Debtors182,000.00 CAD248,000.00 CAD
Cash & Equivalents13.13 m CAD30.36 m CAD
Other Assets00
Total Assets16.57 m CAD34.14 m CAD
Liabilities20222021
Creditors within 1 year3.91 m CAD3.92 m CAD
Creditors after 1 year1.02 m CAD561,000.00 CAD
Other Liabilities00
Total Liabilities4.92 m CAD4.48 m CAD
Net assets11.64 m CAD29.66 m CAD
Equity20222021
Called up share capital235.04 m CAD235.04 m CAD
Share Premium00
Profit / Loss-19.37 m CAD-50.09 m CAD
Other Equity11.64 m CAD29.66 m CAD
Preference & Minorities00
Total Capital Employed11.64 m CAD29.66 m CAD
Ratios20222021
Debt Ratio0.04 CAD0.00 CAD
Debt-to-Equity0.05 CAD0.00 CAD
Assets / Equity1.78671.7867
Cash / Equity1.07091.0709
EPS-0.09 CAD-0.23 CAD
Cash Flow20222021
Cash from operating activities-16.34 m CAD-12.54 m CAD
Cashflow before financing-16.62 m CAD29.36 m CAD
Increase in Cash-16.93 m CAD29.29 m CAD
Income20222021
Turnover638,000.00 CAD2.57 m CAD
Cost of sales351,000.00 CAD1.31 m CAD
Gross Profit287,000.00 CAD1.25 m CAD
Operating Profit-18.76 m CAD-17.52 m CAD
Pre-Tax profit-19.37 m CAD-50.09 m CAD

Ondine Biomedical Inc. Company Background

SectorHealthcare
ActivitiesOndine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportableoperating segment that is antimicrobial photodynamic therapy (aPDT) products.
Latest Interim Date25 Sep 2023
Latest Fiscal Year End Date10 May 2024

Ondine Biomedical Inc. Directors

AppointedNamePosition
2024-01-26Mr. Craig A. ToomanNon-Executive Director
2024-01-26Ms. Carolyn CrossExecutive Director,Chief Executive Officer
2011-09-06Mr. Colin D. WattExecutive Director
2024-01-26Dr. Nicholas LoebelPresident and Chief Technology Officer
2011-09-06Mr. Michael CraneExecutive Director
2011-09-06Mr. Terry M. HollandExecutive Director
2011-09-06Ms. Margaret ShawExecutive Director
2010-12-21Dr. Merrill BielExecutive Director
2011-08-09Mr. Pierre LeducExecutive Director,Chairman
2024-01-26Dr. Simon SinclairNon-Executive Director

Ondine Biomedical Inc. Contact Details

Company NameOndine Biomedical Inc
Address1100 Melville Street, Suite 888, Vancouver, V6E4A6
Telephone+1 604 669-0555
Websitehttps://www.ondinebio.com

Ondine Biomedical Inc. Advisors

AuditorErnst & Young LLP
AuditorErnst & Young Ltd.
AuditorDavidson & Company LLP
Phone+1 604 687-0947

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
09 May 2024Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Harbour Energy PLC301.107.69
Hays PLC97.904.09
Watches Of Switzerland Group PLC336.803.63
Pz Cussons PLC105.603.33
Marshalls PLC292.503.17
Genuit Group PLC455.503.17